Carregant...
Acute promyelocytic leukemia (APL): remaining challenges towards a cure for all
The application of all-trans retinoic acid (ATRA) and arsenic trioxide (ATO) has revolutionized the treatment of acute promyelocytic leukemia (APL). More than 80–90% of patients are expected to be cured with a combination of ATRA, ATO and/or chemotherapy. In this review, we focus on the remaining ob...
Guardat en:
| Publicat a: | Leuk Lymphoma |
|---|---|
| Autors principals: | , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
2019
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7479633/ https://ncbi.nlm.nih.gov/pubmed/31842650 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/10428194.2019.1613540 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|